Science at Risk: Funding the Future of Medical Innovation

Regenerative medicine using stem cells stands at the forefront of innovation in health care, offering the potential to treat various medical conditions. Yet, despite the promise of this science, recent federal policy changes have created new barriers to funding, conducting, and approving clinical trials and therapies, posing significant challenges to advancing patient care.

This installment of the Baker Institute’s annual policy lecture series brings together physician-scientist Dr. Emerson Perin and patient advocate Micaela Alpert, who will discuss the future of regenerative medicine. The conversation will explore how to streamline regulatory processes, accelerate the review and approval of clinical protocols, and secure funding for research. Co-sponsored by the Baker Institute Center for Health Policy and The Texas Heart Institute, this event is supported by a grant from the George and Mary Josephine Hamman Foundation.

It is free and open to the public.

Follow @BakerInstitute on X to join the conversation online with #BakerLive.

Host or Publisher Rice University's Baker Institute